Business- Page 86

PRINCETON, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company focused on transforming the treatment of urothelial and specialty cancers, today announced that management will present

Global integration gives advertisers access to native, real-time AU reporting across web and CTV, plus automated attention-threshold optimization NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) — Teads (NASDAQ: TEAD), the omnichannel outcomes

Two Invited Presentations Showcase Clinical Progress in Solid Tumors and Allogene’s Broader Vision in Oncology and Autoimmune Disease Preclinical Poster Features Next-Generation DLL3/CD70 Dual CAR T Product Candidate for Small Cell Lung

A recognized technology expert, world-class practitioner and client advisor, Barr will steer Hotwire’s US business SAN FRANCISCO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Hotwire Global, the technology communications and marketing consultancy, has

SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today

Progressing commercial initiatives and advancing value unlock strategy in the Benelux DENVER, Nov. 03, 2026 (GLOBE NEWSWIRE) — Liberty Global Ltd. announces its Q3 2026 financial results. CEO Mike Fries stated, “In

CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) — City Therapeutics, Inc. (Nasdaq: CTY), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics, today announced that management will participate

SUGAR LAND, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global, leading provider of specialty industrial services offering customers access to a full suite

Realignment removes approximately $3.7 million of loan payments scheduled for 2027, ends cash dividends on preferred stock and keeps 100% of new capital in the business Transactions eliminate approximately 90% of Bond’s

Potential to pay as little as $0 per fill for VOQUEZNA, plus free home delivery and prior authorization support, makes it simpler for GERD patients to get the medicine their doctor prescribed